InMed Pharmaceuticals (INM) Gross Profit (2021 - 2025)
InMed Pharmaceuticals (INM) reported Gross Profit of $184,194 for fiscal Q2 2026 (quarter ended Dec 31, 2025), down 60.0% from $460,894 a year earlier and down 54.3% from the prior quarter.
Powered by 
Analysis
InMed Pharmaceuticals (INM) Gross Profit (2021 - 2025) Analysis & Trends
Over the twelve months ended Dec 31, 2025, InMed Pharmaceuticals' Gross Profit came in at $1.34 million, down 21.7% year-over-year; for FY2025 (ended Jun 30, 2025), it was $1.71 million, up 55.0% from FY2024.
- Gross Profit has a three-year compound annual growth rate of 46.4% (FY2022 to FY2025).
- By fiscal year, Gross Profit came in at $1.1 million in FY2024 (-21.5%), $1.4 million in FY2023 (+158.1%) and $543,546 in FY2022.
- Five-year quarterly Gross Profit spans a low of -$491,018 in fiscal Q1 2023 and a high of $1.57 million in fiscal Q4 2023.
- Year over year, Gross Profit gained in three of the last seven quarters, with an average decline of 10.2%.
- The high point for year-over-year Gross Profit in five years was fiscal Q4 2023 (growth of 528.9%); the low point was fiscal Q4 2024 (a decline of 70.3%).
- Per Business Quant data, the three fiscal quarters before Q2 2026 came in at $403,159 (Q1 2026), $576,654 (Q4 2025) and $175,625 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Linde | 218.80 Bn | 201.92 Bn | 4.43 Bn |
| 2 | Corning | 132.43 Bn | 125.56 Bn | 1.63 Bn |
| 3 | Sherwin Williams | 78.49 Bn | 77.53 Bn | 3.34 Bn |
| 4 | Air Products & Chemicals | 61.97 Bn | 59.87 Bn | 1.04 Bn |
| 5 | Corteva | 51.82 Bn | 40.62 Bn | 3.66 Bn |
| 6 | LyondellBasell Industries | 37.12 Bn | 26.74 Bn | 2.04 Bn |
| 7 | Nutrien | 33.86 Bn | 30.73 Bn | 3.25 Bn |
| 8 | Qnity Electronics | 26.31 Bn | 23.73 Bn | 666.00 Mn |
| 9 | Ati | 25.78 Bn | 23.93 Bn | 309.80 Mn |
| 10 | InMed Pharmaceuticals | 5.66 Mn | 3.46 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 184,194.00 |
| Sep 30, 2025 | 403,159.00 |
| Jun 30, 2025 | 576,654.00 |
| Mar 31, 2025 | 175,625.00 |
| Dec 31, 2024 | 460,894.00 |
| Sep 30, 2024 | 493,413.00 |
| Jun 30, 2024 | 466,071.00 |
| Mar 31, 2024 | 289,458.00 |
| Dec 31, 2023 | 324,142.00 |
| Sep 30, 2023 | 21,242.00 |
| Jun 30, 2023 | 1.57 Mn |
| Mar 31, 2023 | 192,511.00 |
| Dec 31, 2022 | 131,163.00 |
| Sep 30, 2022 | -491,018.00 |
| Jun 30, 2022 | 249,714.00 |
| Mar 31, 2022 | 182,277.00 |
| Dec 31, 2021 | 111,555.00 |
API Access
InMed Pharmaceuticals Gross Profit API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gross-profit&ticker=INM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gross-profit", "ticker": "INM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gross-profit&ticker=INM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();